Detalhe da pesquisa
1.
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.
Nat Immunol
; 23(10): 1495-1506, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151395
2.
Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans.
Nat Immunol
; 22(8): 1020-1029, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312547
3.
PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity.
Nat Immunol
; 20(10): 1335-1347, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31527834
4.
Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodeling.
Nat Immunol
; 20(12): 1668-1680, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31636464
5.
Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol
; 20(11): 1556, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582823
6.
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol
; 20(3): 326-336, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30778252
7.
Maintenance of CD4 T cell fitness through regulation of Foxo1.
Nat Immunol
; 19(8): 838-848, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29988091
8.
In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma.
Immunity
; 54(3): 571-585.e6, 2021 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33497609
9.
Targeting TBK1 to overcome resistance to cancer immunotherapy.
Nature
; 615(7950): 158-167, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634707
10.
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity.
Nature
; 595(7866): 309-314, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33953401
11.
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade.
Nature
; 565(7737): 43-48, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559380
12.
TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response.
Nucleic Acids Res
; 50(D1): D1391-D1397, 2022 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534350
13.
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.
Nature
; 547(7664): 413-418, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28723893
14.
Targeted reconstruction of T cell receptor sequence from single cell RNA-seq links CDR3 length to T cell differentiation state.
Nucleic Acids Res
; 45(16): e148, 2017 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28934479
15.
Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells.
J Immunol
; 197(5): 1809-22, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27448585
16.
Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine.
JCI Insight
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687615
17.
Protocol for in vivo CRISPR screening using selective CRISPR antigen removal lentiviral vectors.
STAR Protoc
; 4(1): 102082, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861834
18.
Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening.
Nat Commun
; 14(1): 8048, 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052854
19.
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model.
Front Immunol
; 14: 1297932, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38213329
20.
PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment.
J Immunother Cancer
; 10(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35264433